Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Current Assets (2021 - 2026)

Core Scientific has reported Current Assets over the past 6 years, most recently at $1.5 billion for Q1 2026.

  • Quarterly results put Current Assets at $1.5 billion for Q1 2026, up 74.61% from a year ago — trailing twelve months through Mar 2026 was $1.5 billion (up 74.61% YoY), and the annual figure for FY2025 was $895.5 million, down 0.93%.
  • Current Assets reached $1.5 billion in Q1 2026 per CORZ's latest filing, up from $895.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $1.5 billion in Q1 2026 and bottomed at $85.1 million in Q4 2022.
  • Median Current Assets over the past 5 years was $277.9 million (2024), compared with a mean of $514.9 million.
  • Peak annual rise in Current Assets hit 29480.72% in 2022, while the deepest fall reached 88.75% in 2022.
  • Over 5 years, Current Assets stood at $85.1 million in 2022, then increased by 14.0% to $97.0 million in 2023, then soared by 831.77% to $904.0 million in 2024, then fell by 0.93% to $895.5 million in 2025, then skyrocketed by 62.45% to $1.5 billion in 2026.
  • Business Quant data shows Current Assets for CORZ at $1.5 billion in Q1 2026, $895.5 million in Q4 2025, and $1.1 billion in Q3 2025.